Endocrine Board Review 10th Edition (2018)
Endocrine Board Review 10th Edition (2018)
EBR 2018 in print provides a consolidated review for preparing for certification and recertification. This printed book is comprised of over 200 mock exam questions based on the ABIM blueprint for certification and is an excellent study tool for endocrine fellows preparing for initial certification, practicing physicians preparing to re-certify, or anyone seeking an intensive knowledge assessment.
TO CLAIM CME
- This form is for the Endocrine Board Review 10th Edition book
- To evaluate this activity, complete a post-test, and claim CME
- Click "Start" to the right to begin
Upon completion of this educational activity, learners will be able to demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology; apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders; and successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism.
Endocrine Board Review Chair
Serge A. Jabbour, MD – Thomas Jefferson University Sidney Kimmel Medical College
Richard J. Auchus, MD, PhD – University of Michigan
Carolyn B. Becker, MD – Brigham and Women’s Hospital
Andrea D. Coviello, MD – Duke University School of Medicine
Frances J. Hayes, MD – Massachusetts General Hospital
Laurence Katznelson, MD – Stanford University
Michelle F. Magee, MD – Georgetown University School of Medicine
Kathryn A. Martin, MD – Massachusetts General Hospital
Elizabeth N. Pearce, MD, MSc – Boston University School of Medicine
Abbie L. Young, MS, CGC, ELS(D)
The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Richard J. Auchus, MD, PhD: Novartis Pharmaceuticals: Contracted Research Support & Consultant; Strongbridge Biopharma: Contracted Research Support & Consultant; Millendo Therapeutics: Consultant; Quest Diagnostics: Consultant; Corcept Therapeutics: Consultant; Janssen Pharmaceuticals: Consultant; Spruce Biosciences: Contracted Research Support and Consultant; Neurocrine Biosciences: Contracted Research Support; Diurnal, LTD: Contracted Research Support and Consultant; Viamet Pharmaceuticals: Consultant
Andrea D. Coviello, MD: Novo Nordisk Inc.: Consultant and Speaker
Serge A. Jabbour, MD: AstraZeneca, Eli Lilly & Janssen: Consultant/Advisory boards
Michelle F. Magee, MD: Lilly and Sanofi: Funding for conduct of research studies to the MedStar Health Research Institute; Sanofi: Speaker/Honoraria
The following faculty reported no relevant financial relationships: Carolyn B. Becker, MD; Frances J. Hayes, MD; Laurence Katznelson, MD; Kathryn A. Martin, MD; Elizabeth Pearce, MD
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
CME & MOC
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification (MOC):
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the responsibility of the Endocrine Society to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:
- Provide your board-certification information in your educational profile
- 14.25 ABIM MOC
- 14.25 AMA PRA Category 1 Credits™
- 14.25 CME Certificate of Participation